India Launches HPV Vaccination Drive for Women
Key Points
India is launching a nationwide HPV vaccination drive aimed at eradicating cervical cancer, a significant health concern for women. This initiative is crucial for UPSC aspirants, particularly for GS Paper 2 (Health) and GS Paper 3 (Science & Technology). Last Updated: 25-02-2026
Key Facts About the HPV Vaccination Drive
- The vaccination targets girls aged 14 years and is voluntary and free of cost.
- Vaccinations will be conducted at government health facilities like Ayushman Arogya Mandirs and District Hospitals.
- The vaccine reduces cervical cancer risk by over 85% when administered during teenage years.
- The program uses Merck's Gardasil, a quadrivalent vaccine protecting against HPV types 16, 18, 6, and 11.
- A single-dose regimen is adopted, with an optional second dose after 3 to 5 years.
- Over 500 million doses of the HPV vaccine have been administered globally since 2006.
- The initiative is supported by GAVI and recommended by the National Technical Advisory Group on Immunisation (NTAGI).
- The Union Budget 2024 emphasized vaccination for girls aged 9-14 years.
India's Public Health Advancement
The HPV vaccination drive is a significant step towards improving public health in India, aligning with the nation’s goals to reduce cancer mortality rates and enhance women’s health. By adopting WHO-recommended practices, India aims to match international standards in healthcare, contributing to its socio-economic development.
UPSC Relevance
This topic is relevant for GS Paper 2 (Health, Government Policies) and GS Paper 3 (Science & Technology). In Prelims, questions may focus on the specifics of the HPV vaccine, its types, and the vaccination strategy. For Mains, discussions could revolve around public health strategies and their socio-economic impacts.
FAQ Section
- What is the HPV vaccination drive? The drive is a nationwide initiative to provide free HPV vaccines to girls aged 9-14 years to prevent cervical cancer.
- Why is the HPV vaccination important? It significantly reduces the risk of cervical cancer, which is the second most common cancer among women in India.
- What are the key features of the HPV vaccine used? The vaccine, Gardasil, protects against HPV types 6, 11, 16, and 18, and follows a single-dose regimen with an optional second dose.
Detailed Coverage
- Target Group: Girls aged 14 years, voluntary and free.
- Vaccine Used: Merck's Gardasil, a quadrivalent vaccine.
- HPV Types Covered: 16, 18, 6, and 11.
- Efficacy: Reduces cervical cancer risk by over 85%.
- Single-Dose Regimen: WHO-recommended with an optional second dose.
- Safety: Non-live vaccine with a strong safety record.
- Global Usage: Over 500 million doses administered worldwide.
- Implementation Partner: GAVI, the Vaccine Alliance.
- Campaign Strategy: Conducted on designated immunization days.
- HPV Classification: Low-risk and high-risk types.
- Cervical Cancer Statistics: 80,000 new cases and 42,000 deaths annually in India.
- Transmission: Primarily through intimate skin-to-skin contact.
- Prevention: Vaccination, condom use, and smoking cessation.
- WHO Targets: 90% vaccination and 70% screening by 2030.
- India's Mission: Eliminate cervical cancer with free vaccination.